Skip to main content
TipRanks
Go Ultimate75% OFF

Biosyent (RX) Ratios

56 Followers

Biosyent Ratios

TSE:RX's free cash flow for Q3 2026 was C$6.28M. For the 2026 fiscal year, TSE:RX's free cash flow was decreased by C$-21.93K and operating cash flow was C$6.31M. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio5.514.536.486.498.24
Quick Ratio4.633.545.425.707.70
Cash Ratio2.812.241.441.384.36
Solvency Ratio1.241.241.020.831.20
Operating Cash Flow Ratio1.331.600.910.871.13
Short-Term Operating Cash Flow Coverage0.0044.060.000.000.00
Net Current Asset ValueC$ 31.82MC$ 18.11MC$ 29.10MC$ 30.02MC$ 28.47M
Leverage Ratios
Debt-to-Assets Ratio0.020.030.030.030.04
Debt-to-Equity Ratio0.020.030.040.040.05
Debt-to-Capital Ratio0.020.030.030.040.05
Long-Term Debt-to-Capital Ratio0.000.000.000.000.00
Financial Leverage Ratio1.191.181.191.211.18
Debt Service Coverage Ratio185.3630.96102.0970.7976.76
Interest Coverage Ratio229.23147.98109.2190.5196.00
Debt to Market Cap0.000.000.000.000.00
Interest Debt Per Share0.080.090.110.120.13
Net Debt to EBITDA-1.60-1.06-0.75-0.87-1.91
Profitability Margins
Gross Profit Margin74.59%79.52%81.03%81.85%79.10%
EBIT Margin26.28%28.09%27.23%25.00%28.59%
EBITDA Margin28.26%29.78%28.67%26.62%30.19%
Operating Profit Margin26.28%24.99%23.65%25.00%28.59%
Pretax Profit Margin27.94%27.93%27.01%26.61%29.28%
Net Profit Margin20.93%20.75%20.45%19.55%21.95%
Continuous Operations Profit Margin20.93%20.75%20.45%19.55%21.95%
Net Income Per EBT74.91%74.32%75.70%73.46%74.97%
EBT Per EBIT106.34%111.76%114.22%106.43%102.39%
Return on Assets (ROA)18.23%17.58%15.56%13.48%16.90%
Return on Equity (ROE)21.73%20.77%18.59%16.36%19.91%
Return on Capital Employed (ROCE)26.79%24.34%20.76%20.08%24.77%
Return on Invested Capital (ROIC)19.97%17.90%15.63%14.68%18.48%
Return on Tangible Assets20.19%20.02%16.00%13.89%17.31%
Earnings Yield6.29%5.70%6.04%6.34%5.99%
Efficiency Ratios
Receivables Turnover9.4911.708.917.648.92
Payables Turnover1.781.791.181.001.68
Inventory Turnover1.711.351.021.122.71
Fixed Asset Turnover43.8129.1721.9416.6914.82
Asset Turnover0.870.850.760.690.77
Working Capital Turnover Ratio1.671.421.020.911.05
Cash Conversion Cycle47.4298.8290.739.80-42.02
Days of Sales Outstanding38.4631.2040.9847.8040.91
Days of Inventory Outstanding214.04271.05359.04326.68134.54
Days of Payables Outstanding205.09203.44309.29364.68217.47
Operating Cycle252.51302.25400.02374.48175.44
Cash Flow Ratios
Operating Cash Flow Per Share0.850.750.420.400.37
Free Cash Flow Per Share0.850.340.410.360.36
Dividend Paid and CapEx Coverage Ratio4.171.282.424.9350.17
Capital Expenditure Coverage Ratio177.991.8629.019.5350.17
Operating Cash Flow Coverage Ratio11.448.354.143.553.00
Operating Cash Flow to Sales Ratio0.220.250.160.180.16
Free Cash Flow Yield6.67%3.13%4.56%5.14%4.37%
Valuation Ratios
Price-to-Earnings (P/E) Ratio15.9117.4616.5615.7816.69
Price-to-Sales (P/S) Ratio3.333.643.393.083.66
Price-to-Book (P/B) Ratio3.463.643.082.583.32
Price-to-Free Cash Flow (P/FCF) Ratio14.9931.9121.9119.4422.88
Price-to-Operating Cash Flow Ratio14.9014.7121.1617.4022.42
Price-to-Earnings Growth (PEG) Ratio0.591.050.73-1.310.23
Enterprise Value Multiple10.1911.1611.0610.7210.22
Enterprise Value123.92M116.38M100.19M79.65M88.33M
EV to EBITDA10.1911.1611.0610.7210.22
EV to Sales2.883.323.172.853.09
EV to Free Cash Flow12.9529.1420.5317.9819.28
EV to Operating Cash Flow12.8813.4319.8216.1018.90
Tangible Book Value Per Share3.262.592.812.612.42
Shareholders’ Equity Per Share3.683.022.912.712.49
Tax and Other Ratios
Effective Tax Rate0.250.260.240.270.25
Revenue Per Share3.823.022.642.272.26
Net Income Per Share0.800.630.540.440.50
Tax Burden0.750.740.760.730.75
Interest Burden1.060.990.991.061.02
Research & Development to Revenue0.010.000.000.010.01
SG&A to Revenue0.460.500.310.320.16
Stock-Based Compensation to Revenue0.010.020.020.020.01
Income Quality1.071.190.780.910.74

Currency in CAD